<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>It has been demonstrated that <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL) recognize <z:chebi fb="0" ids="53000">epitopes</z:chebi> formed by anionic <z:chebi fb="1" ids="16247">phospholipids</z:chebi> and protein cofactors. beta 2 glycoprotein I (beta 2GPI) is accepted as the cofactor of anticardiolipin antibodies (aCL) </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study we explored the presence and clinical associations of anti beta 2GPI antibodies of IgG isotype (a beta 2GPI-IgG), measured by ELISA </plain></SENT>
<SENT sid="2" pm="."><plain>We studied sera from 169 patients with aCL and/or <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA), including 52 patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> and 49 with <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> (PAPS) </plain></SENT>
<SENT sid="3" pm="."><plain>We found 31.9% positive sera for a beta 2GPI-IgG in the whole population and 48.6% in the aCL-IgG(+) group </plain></SENT>
<SENT sid="4" pm="."><plain>There was a good correlation between the titre of aCL-IgG and the optical density for a beta 2GPI-IgG (r = 0.69, P &lt; 0.01) </plain></SENT>
<SENT sid="5" pm="."><plain>The presence of a beta 2GPI-IgG was associated with the presence of aCL-IgG (P &lt; 0.0001) and LA (P &lt; 0.0005) </plain></SENT>
<SENT sid="6" pm="."><plain>However, none of 23 LA (+) patients without aCL had a beta 2GPI-IgG </plain></SENT>
<SENT sid="7" pm="."><plain>We found a statistically significant association between the presence of a beta 2GPI-IgG and a history of venous <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> (VTE) in our patients (P &lt; 0.005) </plain></SENT>
<SENT sid="8" pm="."><plain>This association was observed in PAPS (P &lt; 0.05) but not in <z:e sem="disease" ids="C0409983" disease_type="Disease or Syndrome" abbrv="">secondary antiphospholipid syndrome</z:e> (SAPS) </plain></SENT>
<SENT sid="9" pm="."><plain>Our study confirms that some aPL(+) sera react with beta 2GPI in special experimental conditions </plain></SENT>
<SENT sid="10" pm="."><plain>In addition, the presence of these antibodies is associated with a history of VTE </plain></SENT>
</text></document>